Akèy › Leukemi › Vermont › Burlington
Etid klinik pou Leukemi nan Burlington, VT
4 etid pou Leukemi ap chèche patisipan nan sit nan ak bò kote Burlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Ap rekriteFaz 3
- University of Vermont Medical Center, Burlington
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- University of Vermont, Burlington
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
Ap rekriteEtid obsèvasyon
- University of Vermont Medical Center, Burlington
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Ap rekriteEtid obsèvasyon
- University of Vermont and State Agricultural College, Burlington
Etid Leukemi nan lòt vil
- Houston, TX28 etid
- Boston, MA25 etid
- New York City, NY19 etid
- Los Angeles, CA16 etid
- Chicago, IL16 etid
- Durham, NC13 etid
- Baldwin Park, CA12 etid
- Columbus, OH12 etid
- Nashville, TN12 etid
- Philadelphia, PA12 etid
- Milwaukee, WI11 etid
- Atlanta, GA11 etid
Lòt etid nan Burlington
- Ensifizyans kadyak8 etid
- Leksemi mieloïd egi7 etid
- Kansè (tout kalite)6 etid
- BPCO5 etid
- Kansè nan tete5 etid
- Maladi Parkinson4 etid
- Kansè Poumon ki pa ti selil4 etid
- Kansè pwostat4 etid
- Fibroz sistik4 etid
- Maladi poumon4 etid
- Maladi kadyovaskilè4 etid
- Kansè Metastatik4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.